1,278
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Clinical Oncology

Overall survival in 92,991 colorectal cancer patients in Germany: differences according to type of comorbidity

ORCID Icon, &
Pages 1931-1938 | Received 08 Sep 2023, Accepted 06 Nov 2023, Published online: 17 Nov 2023

References

  • Schimansky S, Lang S, Beynon R, et al. Association between comorbidity and survival in head and neck cancer: results from head and neck 5000. Head Neck. 2019;41(4):1053–1062. doi: 10.1002/hed.25543.
  • Land LH, Dalton SO, Jorgensen TL, et al. Comorbidity and survival after early breast cancer. A review. Crit Rev Oncol Hematol. 2012;81(2):196–205. doi: 10.1016/j.critrevonc.2011.03.001.
  • Ording AG, Garne JP, Nystrom PMW, et al. Comorbid diseases interact with breast cancer to affect mortality in the first year after diagnosis-A Danish nationwide matched cohort study. PLOS One. 2013;8(10):e76013. doi: 10.1371/journal.pone.0076013.
  • Woelfel IA, Fernandez LJ, Idowu MO, et al. A high burden of comorbid conditions leads to decreased survival in breast cancer. Gland Surg. 2018;7(2):216–227. doi: 10.21037/gs.2018.02.03.
  • Bradley CJ, Dahman B, Anscher M. Prostate cancer treatment and survival evidence for men with prevalent comorbid conditions. Med Care. 2014;52(6):482–489. doi: 10.1097/MLR.0000000000000113.
  • Luchtenborg M, Jakobsen E, Krasnik M, et al. The effect of comorbidity on stage- specific survival in resected non-small cell lung cancer patients. Eur J Cancer. 2012;48(18):3386–3395. doi: 10.1016/j.ejca.2012.06.012.
  • Shieh SH, Probst JC, Sung FC, et al. Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes. BMC Cancer. 2012;12(1):174. doi: 10.1186/1471-2407-12-174.
  • Boakye D, Rillmann B, Walter V, et al. Impact of comorbidity and frailty on prognosis in colorectal cancer patients: a systematic review and meta-analysis. Cancer Treat Rev. 2018;64:30–39. doi: 10.1016/j.ctrv.2018.02.003.
  • Iversen LH, Norgaard M, Jacobsen J, et al. The impact of comorbidity on survival of danish colorectal cancer patients from 1995 to 2006-A population-based cohort study. Dis Colon Rectum. 2009;52(1):71–78. doi: 10.1007/DCR.0b013e3181974384.
  • Kisely S, Crowe E, Lawrence D. Cancer-related mortality in people with mental illness. JAMA Psychiatry. 2013;70(2):209–217. doi: 10.1001/jamapsychiatry.2013.278.
  • Boakye D, Nagrini R, Ahrens W, et al. The association of comorbidities with administration of adjuvant chemotherapy in stage III Colon cancer patients: a systematic review and meta-analysis. Ther Adv Med Oncol. 2021;13:1758835920986520. doi: 10.1177/1758835920986520.
  • Batty GD, Whitley E, Gale CR, et al. Impact of mental health problems on case fatality in male cancer patients. Br J Cancer. 2012;106(11):1842–1845. doi: 10.1038/bjc.2012.150.
  • Baillargeon J, Kuo YF, Lin YL, et al. Effect of mental disorders on diagnosis, treatment, and survival of older adults with Colon cancer. J Am Geriatr Soc. 2011;59(7):1268–1273. doi: 10.1111/j.1532-5415.2011.03481.x.
  • Cunningham R, Sarfati D, Stanley J, et al. Cancer survival in the context of mental illness: a national cohort study. Gen Hosp Psychiatry. 2015;37(6):501–506. doi: 10.1016/j.genhosppsych.2015.06.003.
  • Kisely S, Forsyth S, Lawrence D. Why do psychiatric patients have higher cancer mortality rates when cancer incidence is the same or lower? Aust N Z J Psychiatry. 2016;50(3):254–263. doi: 10.1177/0004867415577979.
  • Chang CK, Hayes RD, Broadbent MTM, et al. A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival. BMJ Open. 2014;4(1):e004295. doi: 10.1136/bmjopen-2013-004295.
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
  • Manderbacka K, Arffman M, Lumme S, et al. The effect of history of severe mental illness on mortality in colorectal cancer cases: a register-based cohort study. Acta Oncol. 2018;57(6):759–764. doi: 10.1080/0284186X.2018.1429649.
  • Haug U, Schink T. German pharmacoepidemiological research database (GePaRD). In: sturkenboom M, Schink T, editors. Databases for pharmacoepidemiological research. Cham, Switzerland: Springer; 2021.
  • Schwarz S, Hornschuch M, Pox C, et al. Colorectal cancer after screening colonoscopy: 10-year incidence by site and detection rate at first repeat colonoscopy. Clin Transl Gastroenterol. 2023;14(1):e00535. doi: 10.14309/ctg.0000000000000535.
  • Schröder H, Brückner G, Schüssel K, et al. Monitor: vorerkrankungen mit erhöhtem Risiko für schwere COVID-19-Verläufe. Verbreitung in der Bevölkerung Deutschlands und seinen Regionen. Berlin, 2020.
  • Collett D. Modelling survival data in medical research. 3rd ed. Boca Raton: CRC Press, Taylor & Francis Group, Chapman & Hall; 2015.
  • R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2022.
  • Nayak P, Luo RL, Elting L, et al. Impact of rheumatoid arthritis on the mortality of elderly patients who develop cancer: a population-based study. Arthritis Care Res. 2017;69(1):75–83. doi: 10.1002/acr.22997.
  • Rabeneck L, Souchek J, El-Serag HB. Survival of colorectal cancer patients hospitalized in the veterans affairs health care system. Am J Gastroenterol. 2003;98(5):1186–1192. doi: 10.1111/j.1572-0241.2003.07448.x.
  • Shack LG, Rachet B, Williams EMI, et al. Does the timing of comorbidity affect colorectal cancer survival? A population based study. Postgrad Med J. 2010;86(1012):73–78. doi: 10.1136/pgmj.2009.084566.
  • Marventano S, Grosso G, Mistretta A, et al. Evaluation of four comorbidity indices and charlson comorbidity index adjustment for colorectal cancer patients. Int J Colorectal Dis. 2014;29(9):1159–1169. doi: 10.1007/s00384-014-1972-1.
  • Renzi C, Kaushal A, Emery J, et al. Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms. Nat Rev Clin Oncol. 2019;16(12):746–761. doi: 10.1038/s41571-019-0249-6.
  • Ott A, Breteler MMB, van Harskamp F, et al. Incidence and risk of dementia – The rotterdam study. Am J Epidemiol. 1998;147(6):574–580. doi: 10.1093/oxfordjournals.aje.a009489.
  • Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21(9):655–679. doi: 10.1016/j.euroneuro.2011.07.018.
  • Manderbacka K, Arffman M, Suvisaari J, et al. Effect of stage, comorbidities and treatment on survival among cancer patients with or without mental illness. Br J Psychiatry. 2017;211(5):304–309. doi: 10.1192/bjp.bp.117.198952.
  • Ribe AR, Laurberg T, Laursen TM, et al. Ten-year mortality after a breast cancer diagnosis in women with severe mental illness: a danish population-based cohort study. PLOS One. 2016;11(7):e0158013. doi: 10.1371/journal.pone.0158013.
  • Rich CL, Ricketts JE, Fowler RC, et al. Some differences between men and women who commit suicide. Am J Psychiatry. 1988;145(6):718–722. doi: 10.1176/ajp.145.6.718.
  • Oppelt KA, Luttmann S, Kraywinkel K, et al. Incidence of advanced colorectal cancer in Germany: comparing claims data and cancer registry data. BMC Med Res Methodol. 2019;19(1):142. doi: 10.1186/s12874-019-0784-y.
  • Schwarz S, Hornschuch M, Pox C, et al. Polyp detection rate and cumulative incidence of post-colonoscopy colorectal cancer in Germany. Int J Cancer. 2023;152(8):1547–1555. doi: 10.1002/ijc.34375.
  • Al-Husseini MJ, Saad AM, Mohamed HH, et al. Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria. BMC Cancer. 2019;19(1):863. doi: 10.1186/s12885-019-6074-6.
  • Walter V, Jansen L, Ulrich A, et al. Alcohol consumption and survival of colorectal cancer patients: a population-based study from Germany. Am J Clin Nutr. 2016;103(6):1497–1506. doi: 10.3945/ajcn.115.127092.
  • Fassmer A, Schink T. Repräsentativität von ambulanten Arzneiverordnungen in der German Pharamcoepidemiological Research Database (GePaRD). Paper presented at the 9. Jahrestagung der Deutschen Gesellschaft für Epidemiologie (DGEpi). Ulm, 17-20. 2014.